Chr. Hansen cites 11 percent growth in H1

Chr. Hansen cites 11 percent growth in H1

Company saw 11 percent organic growth for the first half of 2011-2012, excluding carmine price effect, and a 19 percent increase in EBIT.

With organic growth of 11 percent in the first half of financial year 2011/12, Chr. Hansen continues to show solid performance. Initiating a share buy-back program, Chr. Hansen distributes excess capital to its shareholders.

"We are pleased to have continued the solid sales and earnings growth during Q2 2011/12, delivering 11 percent organic growth for the first half of 2011/12 (excluding carmine price effect) and a 19 percent increase in EBIT," comments CEO Lars Frederiksen.

"All our divisions contributed positively and especially the Cultures & Enzymes Division has proved our resilient business model with strong growth despite the continued uncertainty around probiotic health claims in EU. Based on the solid performance in the first half we have narrowed our organic growth target from 7-10 percent to 8-10 percent (excluding carmine price effect).

As a result of Chr. Hansen’s strong cash generation the Board of Directors has decided to initiate a share buy-back program of up to EUR 80 million with the purpose to adjust our capital structure by distributing excess capital to the shareholders," says Lars Frederiksen.

Highlights

  • Revenue EUR 333 million, up 9 percent compared to first half 2010/11
  • Organic growth 11 percent (adjusted for change in sales prices to reflect changes in raw material prices for carmine)
  • EBIT EUR 83 million, up 19 percent compared to first half 2010/11. EBIT margin before special items 25 percent compared to 23 percent in first half last year
  • Q2 2011/12 revenue EUR 165 million, up 7 percent compared to Q2 last year. Organic growth 9 percent (adjusted for change in sales prices to changes in raw material prices for carmine). Operating profit (EBIT) margin reached 25 percent compared to 23 percent in Q2 last year


Outlook

  • As a result of the solid performance in first half the organic growth, excluding effect on sales prices from change in raw material prices for carmine, is now expected to be in the range of 8-10 percent compared to 7-10 percent in the announcement on 11 January 2012
  • EBIT margin before special items is still expected to be above 26 percent

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish